NCT01438554: Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma |
|
|
| Completed | 1 | 89 | US | Pazopanib, Votrient, GSK1120212, Trametinib, Mekinist | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Comprehensive Cancer Network, Novartis | Solid Tumors, Thyroid Cancer, Soft-tissue Sarcoma, Cholangiocarcinoma | 04/16 | 08/18 | | |